Tuesday, December 13, 2016

Technology to support clinical decision-helping to save lives – Portal Nacional de Seguros

If you ask a doctor what would now be your main challenge, surely he would have an answer ready: to do more, in less time, consuming fewer resources and ensuring the efficiency and quality of patient care, all this under constant pressure. In this context, what can really help the health professionals to be more effective in its mission to save lives? The technology has been a strong ally, contributing in different ways. So much so that the area of health is today one of the main bets of the technology industry, at a global level. Is by the benefits that it can bring to the patients or by the impacts on the day-to-day of the doctors.

One technology in particular has responded very well to the main challenges identified by the doctors: the tools to support clinical decision-making, also known as CDS (Clinical Decision Support). This is workflow technology, which enables physicians to support their decisions with information based on evidence related to diagnostics, treatment recommendations and prescription of medicines. It ensures quick access to accurate information, during the assistance to the patient, that is when they need it most, and the most convenient way.

The advent of technology to support decision making in the clinic has been driven by a number of factors: human needs, the needs of the economy in the area of health, and the evolution that technology itself has provided. One of the aspects leading strengthening this growth is the desire to minimize the high variability of care for the patients. There is no reason the actual that explain why a patient receives different treatments depending on the doctor that meets or geographic region where you reside, especially when there is a huge amount of clinical evidence that may support specific approaches. However, this enormous variety of procedures continues to be quite common throughout the world, to a large extent by the lack of a unified base of information that enables decision making.

Another agent motivator for the growing adoption of technologies that support clinical decision-making is the explosion of the volume of information of a medical nature. The scientific knowledge remains in full evolution, leading to the development of new drugs, treatments and diagnostic tests. Thus, doctors face the difficult task of having to continuously update their knowledge, to such a point they will feel confident even to change conduct established. The task of keeping up-to-date with all the advances of medicine and apply in day-to-day for the latest recommendations, is a challenge. But it is precisely the possibility of changing conduct medical one of the main advantages of this type of tool, the benefit that is directly reflected in the quality of patient care. Way too fast, it is possible to find answers many times are not even in the books, in order to support a more complex case, for example.

The technology in general, and to support clinical decision-making in particular, assists in a definitive way the doctors take the right decisions at the right time, helping patients receive the safest and best care, at the same time that delivery efficiency. For this reason, it has a crucial role in the mission to save lives.

Peter Bonis, Chief Medical Officer (CMO) of the Business Unit Clinical Effectiveness of Wolters Kluwer, a global leader in the provision of information for professionals and students in the area of health, which has developed the solution to support the medical decisions UpToDate®

About Wolters Kluwer Health

Wolters Kluwer is a global leader in professional services, information. Professionals in legal, business, tax, accounting, finance, audit, risk, compliance, and healthcare rely on tools, market-leading-enabled information and software solutions from Wolters Kluwer manage your business more efficiently, delivering results to its clients and helping them be more successful in a world that is increasingly dynamic.

Wolters Kluwer reported an annual revenue in 2015 of €4.2 billion. The group serves customers in more than 180 countries and employs more than 19 thousand people all over the world. The company is headquartered in Alphen aan den Rijn, in the Netherlands.

Its shares are quoted on Euronext Amsterdam (WKL) and are included in the indices AEX and Euronext 100. The Wolters Kluwer has a program of Level 1, sponsored by American Depositary Receipts. The company’s ADRs are traded in the OTC market (over-the-counter) in the U.s. (WTKWY).

The Wolters Kluwer Health is part of Wolters Kluwer, a global company market leader in information services. For more information about our products and about the company, visit www.wolterskluwer.com follow @WKHealth or @Wolters_Kluwer on Twitter, “like” us on Facebook, follow us on LinkedIn or WoltersKluwerComms on YouTube.

LikeTweet

No comments:

Post a Comment